RankingsPricing
  1. US-listed companies
  2. ABEONA THERAPEUTICS INC.
  3. Raw

ABEONA THERAPEUTICS INC.ABEO

Market cap
$255.78M
P/E ratio
SummaryFinancials
Back to summarized table
Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022		Dec 31,
2023		Dec 31,
2024
License and other revenues---------10314-
Royalties-----------02-
Research and development42884,000333,0005111739493034293134
General and administrative4---14131120212423171930
Gain on operating lease right-of-use assets------------1-
Total expenses1096420252961779193525164
Loss from operations-7,876,000-4,316,000-3,804,000-3,131,000-18,546,000-23,881,000-27,836,000-58,166,000-77,090,000-81,420,000-89,836,000-51-47-64
Interest income-----------024
Interest expense----------4104
Change in fair value of warrant and derivative liabilities------------11121
Other income5-6,216,0008-23,647,00042517,000-----31
Net loss-2,532,000-10,532,0004-26,778,000-14,526,000-21,873,000-27,319,000-56,671,000-76,282,000-84,234,000-84,936,000-40-54-64
Basic loss per common share--0.06-15.26--------5.53-2.53-1.55
Dilutive loss per common share--0.06-15.26--------5.53-2.53-1.55
Change in unrealized gains related to available-for-sale debt securities----------10,0009,000-000
Comprehensive loss----------84,244,000-84,953,000-44-54-64